State Ledger
Company profile

Annovis Bio, Inc. CIK 1477845

Ticker
ANVS (NYSE)
Industry
Pharmaceutical Preparations
Headquarters
Malvern, PA 19355
Fiscal year end
2025 (FY)
Market Data
Close
$1.22
Change
+$0.04
Change %
3.39%
Volume
35,246

ANVS · trading date Oct 9, 2026 · previous close $1.18 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$0
Net income
-$28.85M
Total assets
$21.08M
Total liabilities
$4.23M
Stockholders' equity
$16.85M
Cash & equivalents
$19.53M
Operating income
-$29.70M
Operating cash flow
-$25.62M
Capital expenditures
—

Fiscal year 2025, via 10-K filed 2026-03-13. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
20.1%
Equity / assets
79.9%
CapEx / revenue
—
Operating cash flow / net income
0.89×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $0 -$28.85M $21.08M $4.23M $16.85M
2024 $0 -$24.59M $13.93M $4.62M $9.31M
2023 $0 -$56.20M $10.21M $17.96M -$7.75M
2022 $0 -$25.33M $36.02M $7.70M $28.32M
2021 $0 -$14.49M $46.00M $1.51M $44.49M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form DEF 14A
2026-09-11
Financials filed via
Form 10-K
filed 2026-03-13

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Malvern, PA 19355
101 LINDENWOOD DRIVE, SUITE 225
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 16:04 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Pennsylvania — Public Companies